Analgesic nephropathy diagnostic study of choice

	Analgesic nephropathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Analgesic nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
Treatment
Medical Therapy
Future or Investigational Therapies
Case Studies
Case #1
Analgesic nephropathy diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Analgesic nephropathy diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Analgesic nephropathy diagnostic study of choice
CDC on Analgesic nephropathy diagnostic study of choice
Analgesic nephropathy diagnostic study of choice in the news
Blogs on Analgesic nephropathy diagnostic study of choice
Directions to Hospitals Treating Analgesic nephropathy
Risk calculators and risk factors for Analgesic nephropathy diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD [2]

Overview

Renal biopsy is the diagnostic study of choice.^[1]
However, renal biopsy is an invasive procedure and there is risk of complications, therefore CT scan without contrast of the abdomen is usually preferred.^[1]^[2]

↑ ^1.0 ^1.1 Template:Cite
↑ de Broe ME, Elseviers MM (1998). "Analgesic nephropathy". N. Engl. J. Med. 338 (7): 446–52. PMID 9459649. Unknown parameter |month= ignored (help)